Stephanie A. Haddad, Hematology/Oncology Fellow Physician and Wellness Chief Fellow at Mays Cancer Center at UT Health San Antonio, shared some highlights from this year’s San Antonio Breast Cancer Symposium (SABCS 2025):
“An exceptional day at the OncLive Breast Oncology Fellows Forum, presenting, getting feedback, networking, and gaining invaluable advice for career development! Kicking off SABCS25!”
“Day 1 of SABCS is underway! Great session starting on Risk Assessment and Management in Young Women.”
“Day 1 at SABCS is a wrap! A strong start filled with excellent sessions, insightful data, and great conversations with colleagues and friends. Excited for what’s to come at SABCS25!”
“Day 1 of SABCS spotted Virginia Kaklamani and Kate Lathrop outside of the clinic!”
“Great summary of novel oral endocrine therapies as Erica Mayer discussed in advancing treatments post-CDK 4/6i in HR+/HER2 – MBC.”
“Kicking off Day 2 of SABCS with the fabulous Virginia Kaklamani giving meeting highlights!”
“Great presentation by Erika Hamilton on HER2CLIMB-05 results.”
“Interesting and surprising results of ASCENT07 presented by Komal Jhaveri at SABCS.”
“Beyond proud of Krishna Doshi on her poster presentation on real-world data on the impact of PT/OT referrals on lymphedema at SABCS! Also, my first poster presentation as a senior author!”
“Love seeing our Breast RNs at SABCS.”
“Great presentation by Aditya Bardia on the LidERA positive results.”
“Closing out Day 2 of SABCS25 with great data, presentations, and smiles!”
“Emerging data on the effects of GLP-1RA on BC SABCS25
GLP1RA is associated with a reduction in all-cause mortality in BC with obesity on ET
GLP1RA is not associated with decreased pCR rates in Hispanics with TNBC.”
“Excited to present my poster presentation on a real-world correlation analysis in TNBC patients who received neoadjuvant KN522.”
“Day 3 of SABCS underway with breaks to catch up with colleagues and friends.”
“Spotted Virginia Kaklamani and Kate Lathrop with special guest Heather McArthur late into Day 3 of SABCS.”
“The highlights of Day 3 at SABCS25! Some of the key data presented and more!
- VIKTORIA1- 2L after ET + CDK4/6i in HR+ mBC
- PATINA – 1L for HR+/HER2+ mBC
- AMBRE – 1L in HR+ mBC w. high tumor burden.”
“Day 4 of SABCS25! Come by PS05-06-02 to learn about a case of CDK-4/6i induced ILD, a very rare but severe complication in breast cancer treatment. I’m incredibly honored to be standing alongside Gayle, the patient who inspired this case report.
posted with patient permission.”
“Day 4 of SABCS is underway with more data and updates!”
You can find more posts featuring Stephanie A. Haddad on OncoDaily.